1 / 10

“Life Sciences in an Oil City”

World-Class Research. “Life Sciences in an Oil City”. Aberdeen’s Nobel Laureates. Spin outs created 2009 - 2012. Source: PraxisUnico Spinout UK Survey, Annual Report 2013

penny
Download Presentation

“Life Sciences in an Oil City”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. World-Class Research “Life Sciences in an Oil City”

  2. Aberdeen’s Nobel Laureates

  3. Spin outs created2009 - 2012 Source: PraxisUnico Spinout UK Survey, Annual Report 2013 Note: Spin-outs are defined as companies formed to exploit intellectual property owned by a university and do not include start-ups, which are formed without IP

  4. Strategy & Support for Knowledge Exchange • Create a culture and training to incentivise staff • Bio-business and entrepreneurship at undergrad and post-grad levels • Co-founders of £25 m VC fund for Life Sciences with Edinburgh & Glasgow Universities, Scottish Enterprise, EIB, Strathclyde Pension Fund

  5. Creating a life science cluster • Gov funded science Life Sciences Innovation 1 GT Biologics Ltd Haptogen formed in 2002 Sold to Wyeth in 2007 Became Pfizer in 2009 On-going collaborative relationship Return of IP to create new businesses

  6. Attracting inward investment TauRX

  7. TauRx Therapeutics announces successful Phase 2 Clinical Trial

  8. Attracting inward investment; TauRx Therapeutics • University and founders (CEO Prof Claude Wischik) • spun-out in 2002 • Raised around US $380 m of investment – primarily from sources in Far East and Canada • Phase III trial, started 2013

  9. Scottish life sciences award winner 07 February 2014 Life Science Business Leadership (2013) NovaBioticsLtd, Aberdeen Dr Deborah A O'Neil • Investment from Angel investors • Phase II clinical trials • Signed licence deal withTaro Inc

  10. Collaboration is key to finding answers to big problems • “I would like encourage academic, clinical and commercial Life Science colleagues to consider routes to regional collaboration fuelled by our commitment to science excellence and common experience of Life Science Research in an Oil City”

More Related